Location
France, Europe
Cheque size
$12M - $25M
Investment Stage
Series A
Series B
Series C
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
EnergyTech
Medical Devices
About Investor
Yuexin Yu is a Director in the Life Sciences team at Andera Partners. Andera’s life sciences platform is focused on life sciences and biotechnologies, and Yu’s own background is deeply rooted in healthcare investing and pharma. Before joining Andera, he worked at 3H Health Investment in Hong Kong and Shanghai, where he backed companies including InnoCare, KeyMed, CanSino, RareStone, EdiGen, Imperative Care, and HeMo Bioengineering. Earlier in his career, he worked at Merck on the life-cycle management of Remicade and Keytruda.
Similar Investors
CP
Christopher Priebe
United Kingdom, Europe
$10K - $12M
Seed
,Series A
,MT
Matthias Tepel
United Kingdom, Europe
$10K - $12M
Seed
,Series A
,TM
Tom Maughan
United Kingdom, Europe
$1M - $100M
Seed
,Series A
,BJ
Bart de Jong
United Kingdom, Europe
$20M - $25M
Series A
,Series B
,CS
Christian Strain
France, Europe
$5M - $50M
Series B
,FL
Fabio Longo
United Kingdom, Europe
$1M - $100M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.